Rhys D.O. Jones

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

Barbara J. Ring, Jenny Y. Chien, Kimberly K. Adkison et al. · Journal of Pharmaceutical Sciences · 2011 · 198 citations

Pharmacokinetic Modeling, Medicine, Drug Discovery +8

PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach

Patrick Poulin, Rhys D.O. Jones, Hannah M. Jones et al. · Journal of Pharmaceutical Sciences · 2011 · 170 citations

Precision Dosing, Physiologically Based Pharmacokinetics, Pharmacokinetic Modeling +9

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution

Rhys D.O. Jones, Hannah M. Jones, Malcolm Rowland et al. · Journal of Pharmaceutical Sciences · 2011 · 133 citations

Translational Medicine, Pharmacokinetic Modeling, Part 2 +11

Establishing <i>in vitro in vivo</i> correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics

Lindsay B. Avery, Jason Wade, Mengmeng Wang et al. · mAbs · 2017 · 97 citations · Full text

Immunocytochemical Technique, Immunology, Pathology +21

Applications of Quantitative Systems Pharmacology in Model‐Informed Drug Discovery: Perspective on Impact and Opportunities

Erica L. Bradshaw, Mary E. Spilker, Richard Zang et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 85 citations · Full text